Edition:
United States

Enanta Pharmaceuticals Inc (ENTA.OQ)

ENTA.OQ on NASDAQ Stock Exchange Global Select Market

45.65USD
21 Nov 2017
Change (% chg)

$-4.06 (-8.17%)
Prev Close
$49.71
Open
$47.70
Day's High
$48.05
Day's Low
$44.54
Volume
374,591
Avg. Vol
75,402
52-wk High
$50.89
52-wk Low
$25.92

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Jun '17 7.51 -0.442
Mar '17 8.96 -0.283
Dec 10.42 -0.262
FY 2016 Sep '16 12.84 -0.095
Jun '16 13.98 -0.057
Mar '16 13.00 -0.087
Dec 48.44 1.359
FY 2015 Sep '15 14.42 0.300
Jun '15 11.60 0.125
Mar '15 57.37 1.492
Dec 77.50 2.179
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-17 4 73.80 75.76 72.00 --
Quarter Ending Mar-18 2 16.97 21.00 12.93 --
Year Ending Sep-17 4 100.72 102.65 99.00 --
Year Ending Sep-18 4 78.67 97.00 69.44 --
Year Ending Sep-19 2 100.37 124.00 76.75 --
Earnings (per share)
Quarter Ending Sep-17 4 2.13 2.83 1.81 --
Quarter Ending Mar-18 1 -0.40 -0.40 -0.40 --
Year Ending Sep-17 4 1.16 1.87 0.83 --
Year Ending Sep-18 4 -0.97 -0.46 -1.53 --
Year Ending Sep-19 2 -0.82 -0.62 -1.03 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 200.64 34.68
P/E High - Last 5 Yrs. 23.61 292.78 45.18
P/E Low - Last 5 Yrs. 8.83 96.53 24.20
Beta 0.66 0.85 0.89
Price to Sales (TTM) 23.89 94.15 5.28
Price to Book (MRQ) 3.64 20.33 5.58
Price to Tangible Book (MRQ) 3.64 23.70 7.10
Price to Cash Flow (TTM) -- 105.38 23.65
% Owned Institutions 68.81 6.14 1.28

Dividends

  Company industry sector
Dividend Yield -- 0.29 1.49
Dividend Yield - 5 Year Avg -- 0.26 2.03
Dividend 5 Year Growth Rate -- 2.06 5.31
Payout Ratio(TTM) -- 108.76 45.48

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -46.27 5.37 6.93
Sales (TTM) vs TTM 1 Yr. Ago -55.78 28.55 5.15
Sales - 5 Yr. Growth Rate 16.08 33.75 10.34
EPS (MRQ) vs Qtr. 1 Yr. Ago -679.09 -142.75 4.86
EPS (TTM) vs TTM 1 Yr. Ago -171.31 -- --
EPS - 5 Yr. Growth Rate -3.14 44.56 11.02
Capital Spending - 5 Yr. Growth Rate 60.49 41.86 15.11

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.91 2.54
Current Ratio (MRQ) 18.53 5.57 3.55
LT Debt to Equity (MRQ) 0.22 14.39 12.26
Total Debt to Equity (MRQ) 0.25 16.74 18.26
Interest Coverage (TTM) -- -144.04 43.11

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 43.96 54.73
Gross Margin - 5 Yr. Avg. -- 55.13 52.22
EBITD Margin (TTM) -77.41 -- --
EBITD - 5 Yr. Avg 55.94 -209.76 15.69
Operating Margin (TTM) -82.51 -530.58 8.10
Operating Margin - 5 Yr. Avg. 55.12 -225.54 11.33
Pre-Tax Margin (TTM) -77.11 -498.47 8.95
Pre-Tax Margin - 5 Yr. Avg. 56.20 -225.32 11.74
Net Profit Margin (TTM) -51.85 -495.61 5.18
Net Profit Margin - 5 Yr. Avg. 44.82 -228.41 8.02
Effective Tax Rate (TTM) -- 15.63 24.21
Effective Tax Rate - 5 Yr. Avg. 20.25 19.29 24.06

Efficiency

  Company industry sector
Revenue/Employee (TTM) 522,737 22,793,534 864,771,004
Net Income/Employee (TTM) -271,053 -1,249,347 100,828,627
Receivable Turnover (TTM) 3.70 33.23 6.12
Inventory Turnover (TTM) -- 2.68 3.51
Asset Turnover (TTM) 0.14 0.43 0.97

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -7.39 -7.78 11.38
Return on Assets - 5 Yr. Avg. 22.94 0.15 12.41
Return on Investment (TTM) -7.67 -10.01 14.55
Return on Investment - 5 Yr. Avg. 23.82 3.38 16.25
Return on Equity (TTM) -7.78 -35.77 16.07
Return on Equity - 5 Yr. Avg. 28.94 6.10 17.40
  1 Year 3 Year 5 Year
Sales % -45.13 40.17 16.08
EPS (TTM) % -72.47 -- -3.14
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Enanta Pharmaceuticals Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 3.05 2.36 71 77
13 Week 31.13 23.32 82 47
26 Week 55.98 44.61 88 70
52 Week 65.70 40.02 81 45
YTD 48.39 28.66 76 47
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 68.87%
# of Holders: 192
Total Shares Held: 13,148,009
3 Mo. Net Change: 69,602
# New Positions: 22
# Closed Positions: 17
# Increased Positions: 84
# Reduced Positions: 69
# Net Buyers: 15
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.